The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Nomograms to predict prognosis in pseudomyxoma peritonei: A Peritoneal Surface Oncology Group International (PSOGI) multicenter study.
Shigeki Kusamura
No relevant relationships to disclose
Brendan J. Moran
No relevant relationships to disclose
Paul H. Sugarbaker
No relevant relationships to disclose
Elias Dominique
Research Funding - National french multicentric trials
Dario Baratti
No relevant relationships to disclose
Edward Allen Levine
No relevant relationships to disclose
David L. Morris
Employment or Leadership Position - Pharmaust
Stock Ownership - Pharmaust
Olivier Glehen
No relevant relationships to disclose
Armando Sardi
Expert Testimony - Law office of Keefe Bowman and Bruya
Francois Quenet
No relevant relationships to disclose
Pedro Barrios
No relevant relationships to disclose
Brian W. Loggie
No relevant relationships to disclose
Ignace H.J.T. de Hingh
No relevant relationships to disclose
Wim P. Ceelen
No relevant relationships to disclose
Pompiliu Piso
No relevant relationships to disclose
Santiago Gonzalez-Moreno
No relevant relationships to disclose
Kurt Van der Speeten
No relevant relationships to disclose
Luigi Mariani
No relevant relationships to disclose
Rosalba Miceli
No relevant relationships to disclose
Marcello Deraco
No relevant relationships to disclose